InvestSMART

Capitol Health Limited (ASX: CAJ) - Announcements

DELISTED - Current share price for CAJ : $0.385

ASX company news and announcements for Capitol Health Limited (CAJ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Capitol Health Limited (CAJ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Capitol Health Limited (CAJ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Capitol Health Limited (CAJ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change in substantial holding from WAA 26 Jun 2017 5:49PM $0.260 $0.385 risen by 48.08%
- Restructuring and Management Changes 16 Jun 2017 10:47AM $0.240 $0.385 risen by 60.42%
- Sale of NSW Assets for $81.5m and Guidance 14 Jun 2017 8:56AM $0.200 $0.385 risen by 92.50%
- Becoming a substantial holder from WAM 15 May 2017 5:36PM $0.175 $0.385 risen by 120%
- Becoming a substantial holder from WAA 15 May 2017 5:35PM $0.175 $0.385 risen by 120%
- Enlitic Wins 1 Million Euro Cube Tech Fair Competition 15 May 2017 11:14AM $0.180 $0.385 risen by 113.89%
- Ceasing to be a substantial holder 18 Apr 2017 3:13PM $0.165 $0.385 risen by 133.33%
- Market Update 18 Apr 2017 1:59PM $0.158 $0.385 risen by 144.44%
- Becoming a substantial holder 13 Apr 2017 5:10PM $0.160 $0.385 risen by 140.63%
- Becoming a substantial holder from AEF 13 Apr 2017 12:32AM $0.160 $0.385 risen by 140.63%
- Placement & SPP Allotment Completed, 3B & Cleansing Notice 11 Apr 2017 4:55PM $0.165 $0.385 risen by 133.33%
- Results of Extraordinary General Meeting 5 Apr 2017 4:13PM $0.170 $0.385 risen by 126.47%
- Enlitic, Capitol & Paiyipai Collaborate in China 3 Apr 2017 8:56AM $0.170 $0.385 risen by 126.47%
- Share Purchase Plan Scale-Back Refund 28 Mar 2017 12:46AM $0.160 $0.385 risen by 140.63%
- Share Purchase Plan Oversubscribed 22 Mar 2017 9:54AM $0.150 $0.385 risen by 156.67%
- Waiver from Listing Rule 14.7 14 Mar 2017 10:11AM $0.150 $0.385 risen by 156.67%
- S&P DJ Indices Announces March Quarterly Rebalance 10 Mar 2017 8:19AM $0.155 $0.385 risen by 148.39%
- Notice of Extraordinary General Meeting 2 Mar 2017 8:42AM $0.155 $0.385 risen by 148.39%
- SPP Offer Document 2 Mar 2017 8:42AM $0.155 $0.385 risen by 148.39%
- Cleansing Notice 2 Mar 2017 8:41AM $0.155 $0.385 risen by 148.39%
- Market Presentation - Results, Capital Raising and SPP 28 Feb 2017 9:26AM $0.165 $0.385 risen by 133.33%
- $38.5m Capital Raising to Reduce Leverage 28 Feb 2017 9:25AM $0.165 $0.385 risen by 133.33%
- Final Results for First Half 28 Feb 2017 9:24AM $0.165 $0.385 risen by 133.33%
- Appendix 4D and Half Year Results 28 Feb 2017 9:21AM $0.165 $0.385 risen by 133.33%
- China JV - Diagnostic Imaging Consulting/Clinic Management 20 Feb 2017 2:51PM $0.150 $0.385 risen by 156.67%

576 - 600 of 756 results

Page 24 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.